Valcyte (valganciclovir) - Roche, Tanabe Pharma
Prevymis (letermovir) - Merck (MSD)
Beyond valganciclovir: A meta-analysis of letermovir's safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation. (PubMed, BMC Infect Dis) - Mar 10, 2026 - No abstract available 
Journal • Retrospective data • Review • Cytomegalovirus Infection • Solid Organ Transplantation • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41803770
 
Cheng Liu; Hao Yu; Kewei Xu; Muhammad Usman; Wang He; Xutao Chen; ZhiHan Yuan; Zhouhang Li; Zhuang Tang
 
Mar 10, 2026
 
Prev Next